Tumour budding is a novel marker in breast cancer: the clinical application and future prospects

• Published in: Annals of medicine (Helsinki) Vol. 54; no. 1; pp. 1303 - 1312
• Main Authors: Huang, Ting, Bao, Hui, Meng, Yu-hua, Zhu, Jian-lin, Chu, Xiao-dong, Chu, Xiao-li, Pan, Jing-hua
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 31.12.2022; Taylor & Francis Group
• Subjects: Biomarkers, Tumor; Breast cancer; Breast Neoplasms - diagnosis; Epithelial-Mesenchymal Transition; Female; Humans; Oncology; Prognosis; Review; Tumor Microenvironment; tumour budding; tumour budding; epithelial–mesenchymal transition; Breast cancer

Breast cancer (BC) is a group of markedly heterogeneous tumours. There are many subtypes with different biological behaviours and clinicopathological characteristics, leading to significantly different prognosis. Despite significant advances in the treatment of BC, early metastatic is a critical fac...